Viatris VTRS
NASDAQ VTRS
$16.44 -0.17 (-0.99%)
As of: Sep 9, 2026 · 3:06 PM EDT

Viatris (VTRS) Receivables - Other (2019 - 2026)

Viatris (VTRS) posted Receivables - Other of $545.1 million for Q2 2026, up 9.24% on a QoQ basis from $499.0 million in Q1 2026, and up 17.5% year-over-year from $463.9 million in Q2 2025.

Analysis

Viatris (VTRS) Receivables - Other (2019 - 2026) Analysis & Trends

Viatris has reported Receivables - Other for 8 years, with the latest figure at $545.1 million in Q2 2026.

  • On a quarterly basis, Receivables - Other rose 17.5% year-over-year to $545.1 million in Q2 2026; TTM through Jun 2026 was $545.1 million, a 17.5% increase from a year earlier, with the FY2025 full-year figure at $453.7 million, down 16.9% from the prior year.
  • Receivables - Other was $545.1 million for Q2 2026 at Viatris, up from $499.0 million in the prior quarter.
  • The five-year high for Receivables - Other was $882.5 million in Q2 2024, with the low at $453.7 million in Q4 2025.
  • Average Receivables - Other over 5 years is $589.0 million, with a median of $538.9 million recorded in 2022.
  • The sharpest annual moves came in 2024 and 2025: Receivables - Other jumped 82.49% in 2024, then sank 47.43% in 2025.
  • Over 5 years, Receivables - Other stood at $570.7 million in 2022, then jumped by 53.6% to $876.6 million in 2023, then slumped by 37.71% to $546.0 million in 2024, then declined by 16.9% to $453.7 million in 2025, then gained by 20.15% to $545.1 million in 2026.
  • The last three Receivables - Other figures came in at $545.1 million (Q2 2026), $499.0 million (Q1 2026), and $453.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.53 Bn 38.88 Bn 2.15 Bn
2 Viatris 19.14 Bn 18.25 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.86 Bn 9.69 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.45 Bn 5.33 Bn 334.51 Mn
5 Bausch Health Companies 2.33 Bn 492.63 Mn 2.10 Bn
6 Alvotech 1.51 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.48 Bn 1.12 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 992.90 Mn 702.78 Mn 93.47 Mn
9 Fennec Pharmaceuticals 400.20 Mn 358.95 Mn 17.15 Mn
10 RedHill Biopharma 178.79 Mn 178.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 545.10 Mn
Mar 31, 2026 499.00 Mn
Dec 31, 2025 453.70 Mn
Sep 30, 2025 459.50 Mn
Jun 30, 2025 463.90 Mn
Mar 31, 2025 540.80 Mn
Dec 31, 2024 546.00 Mn
Sep 30, 2024 861.00 Mn
Jun 30, 2024 882.50 Mn
Mar 31, 2024 842.00 Mn
Dec 31, 2023 876.60 Mn
Sep 30, 2023 507.50 Mn
Jun 30, 2023 483.60 Mn
Mar 31, 2023 475.60 Mn
Dec 31, 2022 570.70 Mn
Sep 30, 2022 504.10 Mn
Jun 30, 2022 553.30 Mn
Mar 31, 2022 537.00 Mn
Dec 31, 2021 492.00 Mn
Sep 30, 2021 504.00 Mn